Michael S. Cuffe
CIK 1632835 · EVP and Chief Clinical Officer · last filed 2026-02-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$13.78M
Companies
1
Total Filings
70
Lifetime Open-Market Net
-$31.92M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HCA | EVP and Chief Clinical Officer | 35,580 | $387.18 | $13.78M | -$31.92M | 70 | 2026-02-12 |
Recent Filings · Page 4 of 7
70 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-11-02 | HCA | Mixed | — | -$1.16M | EDGAR |
| 2018-07-30 | HCA | Mixed | −589 | -$1.09M | EDGAR |
| 2018-02-26 | HCA | Mixed | +10,198 | -$665.6K | EDGAR |
| 2018-02-09 | HCA | Mixed | — | -$1.12M | EDGAR |
| 2018-02-07 | HCA | Mixed | +716 | -$27.2K | EDGAR |
| 2018-02-02 | HCA | Grant (A) | — | $0 | EDGAR |
| 2017-12-19 | HCA | Mixed | — | -$166.3K | EDGAR |
| 2017-11-27 | HCA | Mixed | — | -$130.4K | EDGAR |
| 2017-10-19 | HCA | Mixed | — | -$130.4K | EDGAR |
| 2017-09-19 | HCA | Mixed | — | -$134.5K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.